These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9805558)

  • 1. [Antitumor immune reactions in lymphoma].
    Bagot M
    Ann Dermatol Venereol; 1998 Sep; 125(9):628-9. PubMed ID: 9805558
    [No Abstract]   [Full Text] [Related]  

  • 2. Recognition of malignant cells by antibodies to the T-cell antigen receptor: potential for diagnosis.
    Boylston AW; Lancaster FC
    Cancer Cells; 1991 Jun; 3(6):236-8. PubMed ID: 1911036
    [No Abstract]   [Full Text] [Related]  

  • 3. Superantigens: a brief review with special emphasis on dermatologic diseases.
    Solanki LS; Srivastava N; Singh S
    Dermatol Online J; 2008 Feb; 14(2):3. PubMed ID: 18700106
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: implications for more extensive use.
    Benetatos L; Dova L; Baxevanos G; Kolaitis NI; Bourantas KL; Vartholomatos G
    Cytometry B Clin Cytom; 2009 Mar; 76(2):102-6. PubMed ID: 18956469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions.
    Pigozzi B; Bordignon M; Belloni Fortina A; Michelotto G; Alaibac M
    Oncol Rep; 2006 Feb; 15(2):347-51. PubMed ID: 16391853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLA(+) T cells in cutaneous diseases.
    Santamaria-Babí LF
    Eur J Dermatol; 2004; 14(1):13-8. PubMed ID: 14965789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracranial tumors and T lymphocytes].
    Nitta T
    No To Shinkei; 1994 Sep; 46(9):823-33. PubMed ID: 7999439
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.
    Touitou V; Daussy C; Bodaghi B; Camelo S; de Kozak Y; Lehoang P; Naud MC; Varin A; Thillaye-Goldenberg B; Merle-Béral H; Fridman WH; Sautès-Fridman C; Fisson S
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3223-9. PubMed ID: 17591892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.
    Atanackovic D; Panse J; Schafhausen P; Faltz C; Bartels K; Boeters I; Hossfeld DK; Hegewisch-Becker S
    Leuk Res; 2005 Sep; 29(9):1019-27. PubMed ID: 16038728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous CD8 lymphocyte infiltration syndrome associated with human immunodeficiency virus infection].
    Bachelez H
    Ann Dermatol Venereol; 1999 Oct; 126(10):673-4. PubMed ID: 10604002
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of T-cell homing to skin.
    Hwang ST
    Adv Dermatol; 2001; 17():211-41. PubMed ID: 11758117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma.
    McHenry PM; Campbell I; Mackie RM
    Br J Dermatol; 1994 May; 130(5):595-8. PubMed ID: 8204466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope.
    Tumenjargal S; Gellrich S; Linnemann T; Muche JM; Lukowsky A; Audring H; Wiesmüller KH; Sterry W; Walden P
    Eur J Immunol; 2003 Nov; 33(11):3175-85. PubMed ID: 14579286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the possible relationship between staphylococcal superantigens and increased Vbeta5.1 usage in cutaneous T-cell lymphoma.
    Vonderheid EC; Bigler RD; Hou JS
    Br J Dermatol; 2005 Apr; 152(4):825-6; author reply 827. PubMed ID: 15840139
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identical T-cell receptor transcripts in multiple melanoma metastases.
    Schrama D; Fuchs E; Bröcker EB; Thor Straten P; Becker JC
    Cancer Res; 2002 Oct; 62(20):5664-7. PubMed ID: 12384521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells.
    Hombach A; Muche JM; Gerken M; Gellrich S; Heuser C; Pohl C; Sterry W; Abken H
    Gene Ther; 2001 Jun; 8(11):891-5. PubMed ID: 11423937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
    Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
    Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.